Fortress Biotech (FBIO) 10-Q2013 Q1 Quarterly report

Filed: 9 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accreting, accretion, ATM, attainment, autism, Berlin, COBRA, director, dollar, earned, employment, Freie, FU, Harlan, holder, IP, JOELA, Joint, Letter, LSA, maximum, MLV, NK, noncurrent, ordinary, partially, penalty, resignation, resigned, rheumatoid, SAB, salary, secretory, Simplified, sponsored, survive, Territory, thereunder, unpaid, Weisman, written, York

Removed: achieved, administration, aggregate, AICPA, Aid, allocate, American, analyzing, applied, applying, approach, arm, Asphelia, assumed, assumption, attest, automatically, began, behavior, call, Certified, charged, College, commence, committee, complex, compound, consecutive, constructing, contingency, contractually, control, conversion, converted, convertible, covered, customary, data, decline, deem, Deposit, determinable, developmental, dilution, discovered, discussed, distribution, documentation, documented, dose, doubt, drug, enrolled, Europe, evolved, exceed, exercisable, exercised, exist, expensed, exposure, fail, FASB, FDA, feasibility, field, filing, final, finance, firm, fixed, Food, foreign, found, Foundation, free, governing, half, historic, ii, inclusive, incorporate, IND, infusion, initial, institute, institution, insurance, insured, intangible, intended, investor, involving, Iowa, knowledgeable, lack, length, liquidation, liquidity, London, low, managed, met, methodology, migrated, monitoring, netted, observed, occur, opportunity, order, outlined, ova, overseeing, package, Paramount, participate, patient, PCP, PCT, pending, percentage, PLC, portfolio, Practice, preferred, premise, prepaid, presentation, presently, prevailing, progressed, promissory, put, reach, reached, receipt, recommendation, reflected, registered, rely, remediation, renew, repayment, replace, replacement, reproduction, residual, responsible, resulting, royalty, safe, separate, side, Similarly, SOX, standard, steering, stockholder, sublicensee, subsequent, successive, terminated, terminating, testing, theoretical, thereto, transition, treated, ultimate, undetected, University, unrelated, utility, varying

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

FBIO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CORONADO BIOSCIENCES, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Coronado Biosciences, Inc. on Form 10-Q for the quarterly period ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lucy Lu, Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his or her knowledge and belief:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company, as of, and for, the periods presented in the Report.

May 9, 2013


By:		/s/ Lucy Lu, M.D.
		Lucy Lu, M.D.
		Chief Financial Officer
		(Principal Financial Officer)